ABVX
Price:
$110.64
Market Cap:
$7.30B
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengu...[Read more]
Industry
Biotechnology
IPO Date
2023-10-20
Stock Exchange
NASDAQ
Ticker
ABVX
According to Abivax S.A.’s latest financial reports and current stock price. The company's current ROE is 5.08%. This represents a change of -14841.61% compared to the average of -34.44% of the last 4 quarters.
The mean historical ROE of Abivax S.A. over the last ten years is -210.45%. The current 5.08% ROE has changed -2512.79% with respect to the historical average. Over the past ten years (40 quarters), ABVX's ROE was at its highest in in the June 2022 quarter at 3.93%. The ROE was at its lowest in in the December 2022 quarter at -2140.97%.
Average
-210.45%
Median
-119.54%
Minimum
-844.90%
Maximum
-22.24%
Discovering the peaks and valleys of Abivax S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 476.15%
Maximum Annual ROE = -22.24%
Minimum Annual Increase = -91.08%
Minimum Annual ROE = -844.90%
| Year | ROE | Change |
|---|---|---|
| 2024 | -434.26% | 476.15% |
| 2023 | -75.37% | -91.08% |
| 2022 | -844.90% | 416.13% |
| 2021 | -163.70% | -21.97% |
| 2020 | -209.78% | -19.32% |
| 2019 | -260.03% | 469.49% |
| 2018 | -45.66% | 96.03% |
| 2017 | -23.29% | -7.67% |
| 2016 | -25.23% | 13.43% |
| 2015 | -22.24% | 48.57% |
The current ROE of Abivax S.A. (ABVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-451.51%
5-year avg
-345.60%
10-year avg
-210.45%
Abivax S.A.’s ROE is greater than Rhythm Pharmaceuticals, Inc. (-126.11%), greater than Merus N.V. (-48.93%), less than Cytokinetics, Incorporated (232.87%), greater than Axsome Therapeutics, Inc. (-357.21%), less than Halozyme Therapeutics, Inc. (141.55%), greater than Nuvalent, Inc. (-39.47%), greater than Jazz Pharmaceuticals plc (-9.25%), greater than Corcept Therapeutics Incorporated (15.99%), greater than Metsera, Inc. (-79.64%), greater than Madrigal Pharmaceuticals, Inc. (-38.38%),
| Company | ROE | Market cap |
|---|---|---|
| -126.11% | $7.05B | |
| -48.93% | $7.30B | |
| 232.87% | $7.92B | |
| -357.21% | $7.46B | |
| 141.55% | $7.40B | |
| -39.47% | $7.77B | |
| -9.25% | $10.14B | |
| 15.99% | $8.91B | |
| -79.64% | $7.43B | |
| -38.38% | $13.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Abivax S.A.'s ROE?
How is the ROE calculated for Abivax S.A. (ABVX)?
What is the highest ROE for Abivax S.A. (ABVX)?
What is the 3-year average ROE for Abivax S.A. (ABVX)?
What is the 5-year average ROE for Abivax S.A. (ABVX)?
How does the current ROE for Abivax S.A. (ABVX) compare to its historical average?